
Cancer patients could benefit from personalised treatment which experts have called “transformational”.
The University of Leicester has entered into a partnership with biotechnology company Isogenica to develop new immunotherapies.

Cancer patients could benefit from personalised treatment which experts have called “transformational”.
The University of Leicester has entered into a partnership with biotechnology company Isogenica to develop new immunotherapies.